Accepted 18 December 2009 Published online 25 May 2010 in Wiley Online Library (wileyonlinelibrary.com). DOI: /hed.21373
|
|
- Claud Reed
- 5 years ago
- Views:
Transcription
1 ORIGINAL ARTICLE DIMINISHING DIAGNOSIS OF FOLLICULAR THYROID CARCINOMA Kristen J. Otto, MD, 1 Jacqueline S. C. Lam, MBBS, 2 Christina MacMillan, MD, 3 Jeremy L. Freeman, MD, FRCSC 2 1 Department of Otolaryngology and Communicative Sciences, University of Mississippi Medical Center, Jackson, MS. kotto@ent.umsmed.edu 2 Department of Otolaryngology Head and Neck Surgery, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada 3 Department of Laboratory Medicine and Pathobiology, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada Accepted 18 December 2009 Published online 25 May 2010 in Wiley Online Library (wileyonlinelibrary.com). DOI: /hed Correspondence to: K. J. Otto VC 2010 Wiley Periodicals, Inc. Abstract: Background. Follicular carcinomas have been reported as 10% to 15% of thyroid malignancies. Refinements in the histologic criteria applied in the classification of follicular lesions have occurred. We aim to document the true incidence of follicular cancers in a cohort from a high-volume endocrine practice. Methods. Patient charts were reviewed and cancers were classified into major subtypes; papillary cancers were further classified by common variants. Proportions were compared to historic Surveillance, Epidemiology, and End Results (SEER) database proportions. Results. Only 2.7% of patients had follicular carcinoma. The proportion of patients with follicular cancer was less than the reported rates of 10% to 15%, and less than the 6.7% extrapolated from SEER. Conclusion. The proportion of follicular cancers is less than traditionally reported. This change is due to an increased incidence of papillary cancers, and modifications of the histologic criteria used for classification of encapsulated follicular lesions. There are potential prognostic consequences, as follicular cancers have been perceived as more aggressive. VC 2010 Wiley Periodicals, Inc. Head Neck 32: , 2010 Although accounting for only 1% of all reportable malignancies, the number of internationally documented well-differentiated thyroid carcinomas (WDTC) has shown a sustainable rise over the past 30 years. Thyroid cancer has become the seventh leading cause of cancer among white women in the United States. 1 5 There has been considerable debate about the true cause of this apparent rise; whether there is an actual increase in the number of thyroid malignancies developing versus whether more early thyroid cancers are being detected with improved sensitivity in our diagnostic imaging and evolving histopathologic criteria remains to be determined. Either way, few will argue that the number of patients presenting for treatment with WDTC is increasing. It has also long been recognized that in contrast to many malignancies, the treatment for WDTC is remarkably successful, with 5-year survival rates reaching close to 97%. 6 Diminishing Diagnosis of Follicular Thyroid Carcinoma HEAD & NECK DOI /hed December
2 Thyroid cancers comprise a heterogeneous group of malignancies with the most common categories including papillary, follicular, medullary, and poorly differentiated and undifferentiated/anaplastic carcinomas. WDTC typically refers to those tumors of follicular cell origins that are largely indolent in nature, and include papillary and follicular carcinomas. Hürthle cell carcinomas are currently categorized as papillary carcinoma, oncocytic variant; follicular carcinoma, oncocytic variant; or medullary carcinoma, oncocytic variant. This classification schema recognizes that the Hürthle cell change is a metaplastic change in the cell and that the underlying biologic behavior of the tumor depends on whether it is a papillary, follicular, or medullary carcinoma. Making the distinction between the various subtypes of WDTC is important as variations do exist in the recommendations for treatment and the overall prognosis. Classically, papillary carcinomas have been reported to represent approximately 80% of all thyroid malignancies, whereas follicular cancers are reported as 10% to 15%. 1 The problem with these figures is that they fail to account for changing diagnostic criteria and incidence patterns among papillary cancers. A review of the epidemiologic data reveals a 2.4-fold increase in incidence of thyroid cancer over the past 30 years. This increase in incidence is attributable solely to papillary thyroid carcinoma. Further scrutiny of the evidence supporting such a drastic increase in incidence reveals an emerging belief that papillary thyroid carcinoma is currently over-diagnosed and that the current diagnostic criteria are probably inconsistently implemented. This is best exemplified by the fact that papillary thyroid carcinoma lacks a single diagnostic cytologic feature, and even among experienced pathologists, there remains poor diagnostic concordance. 7,8 Furthermore, the histologic classification specific to papillary thyroid carcinomas has undergone drastic revisions over the past 40 years. In 1969, the Armed Forces Institute of Pathology (AFIP) fascicle on thyroid tumors described only 1 histologic variant of papillary carcinoma, whereas by 2004, the World Health Organization (WHO) monograph on tumors of endocrine origin agreed on 15 separate variants. In fact, applying the WHO subtyping schema, many thyroid tumors considered to be follicular thyroid carcinomas in the past, would actually currently be classified as papillary carcinomas of the follicular variant. 9 While many large epidemiologic studies have attempted to redefine the true incidence rates of thyroid cancer subtypes seen currently, the shortcomings of such multi-institutional series are apparent in the lack of diagnostic consensus. Moreover, currently reported incidence rates determined from long-term single-institution studies can be confusing and perhaps misleading to the daily practices of thyroid surgeons and endocrinologists as long-term studies are not reflective of current trends. We attempt to define the true incidence of thyroid cancer subtypes, using a retrospective single-institution model from a busy head and neck endocrine surgery practice. PATIENTS AND METHODS Record Review. With the approval of the Mount Sinai Hospital Research Ethics Board, a retrospective review was undertaken of all patients presenting for thyroidectomy in the 2- year period from January 2006 through December All patients were treated by 1 of 3 head and neck surgeons at Mount Sinai Hospital. Patient charts were reviewed for demographic information, and details regarding the extent of surgery performed, the histologic description of the tumor, and final diagnosis. The primary goal was to pinpoint all patients with a diagnosis of primary thyroid malignancy and create a database from which the incidence of the various subtypes of thyroid cancer could be determined. Cancers were classified into major subtypes: papillary, follicular, Hürthle cell not otherwise specified (NOS), medullary, and undifferentiated/anaplastic. Papillary carcinomas were further classified into 7 common variants: classic, follicular, tall cell, insular, oncocytic, microcarcinomas, and cystic. Patients with benign pathology or cumulative disease foci less than 1 cm were excluded from review. Totals and percentages of major subtypes and minor variants were calculated and compared to previously published historic control proportions. In all, 740 thyroid operations were performed at Mount Sinai Hospital during the study period. Of these, 258 patients (34.9%) met inclusion criteria having a diagnosis of primary thyroid cancer and were able to be entered into the database for incidence comparison Diminishing Diagnosis of Follicular Thyroid Carcinoma HEAD & NECK DOI /hed December 2010
3 Histopathologic Diagnostic Criteria. During this time period, the surgical specimens consisting of hemi-thyroidectomy, subtotal thyroidectomy, or total thyroidectomy, were reviewed and diagnosed by pathologists in our institution who also had experience in fine-needle aspiration (FNA) thyroid cytology. There were 8 pathologists, including 1 with specialty training in head and neck/thyroid pathology. The standard criteria for follicular carcinoma and papillary carcinomas were applied, including the presence of lesional capsular invasion and/or angioinvasion within or outside the capsule for encapsulated neoplasms. In the situation of an encapsulated follicular neoplasm with or without evidence of capsular and/or vascular invasion and with papillary carcinoma nuclei recognized cytologically, a diagnosis of follicular variant of papillary carcinoma was made. The features of papillary carcinoma nuclei were defined as nuclear clearing (optically clear nuclei or Orphan Annie nuclei), numerous nuclear grooves, overlapping, enlargement, nuclear membrane irregularity, and intranuclear pseudoinclusions. Other softer features were micronucleoli, hypereosinophilic ( hard ) colloid, irregularly shaped or elongated follicles, psammoma bodies, and small abortive papillae. The papillary carcinoma nuclei were present either diffusely or in a multifocal pattern throughout the tumor. The Hürthle cell (oncocytic) variant of follicular carcinoma was diagnosed when the criteria for follicular carcinoma were identified, and the follicular cells showed extensive Hürthle cell metaplasia. The Hürthle cell (oncocytic) variant of papillary carcinoma was likewise diagnosed when the findings of either a conventional or follicular variant of papillary carcinoma were present and there was extensive Hürthle cell metaplasia. Two of our cases were diagnosed solely as Hürthle cell carcinomas and were not further categorized as either papillary or follicular carcinomas. FIGURE 1. Breakdown of thyroid cancers diagnosed at Mount Sinai Hospital during [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] Of the 258 patients studied, 205 (79.5%) were women, and 53 (20.5%) were men. The age range of patients included was 16 to 86 years (mean 48, median 48). Of the 258 patients, 218 (84.5%) underwent total thyroidectomy, whereas 40 patients (15.5%) had subtotal or partial thyroidectomy operations. Papillary carcinoma was by far the most common thyroid cancer diagnosis in the study group. Papillary carcinoma was the dominant diagnosis in 243 (94.2%) of 258 cases. An additional 9 cases showed multifocal papillary microcarcinomas but had other concurrent dominant diagnoses, making the total number of cases in which papillary cancer was diagnosed 252. The other diagnoses were as follows: 5 cases (1.9%) of medullary carcinoma, 7 cases (2.7%) of follicular carcinoma, 2 cases (0.8%) of Hürthle cell carcinoma NOS, and 1 case (0.3%) of anaplastic carcinoma (Figure 1). In 60% 9 of these nonpapillary cases, papillary carcinoma foci were identified. There were 7 variants of papillary cancer identified in the study group. The dominant variant was RESULTS FIGURE 2. Breakdown of papillary carcinoma variants diagnosed at Mount Sinai Hospital during [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] Diminishing Diagnosis of Follicular Thyroid Carcinoma HEAD & NECK DOI /hed December
4 follicular variant, identified in 125 of 252 cases (49.6%). Other less commonly identified variants included: 98 cases (38.9%) of classical variant, 4 cases (1.6%) of tall cell variant, 2 cases (0.8%) of insular variant, 9 cases (3.6%) of oncocytic variant, 12 cases (4.8%) of papillary microcarcinoma (cumulative foci were greater than 1 cm in all cases), and 2 cases (0.8%) of cystic variant of papillary carcinoma (Figure 2). DISCUSSION We identified only 7 cases of true follicular thyroid cancer in 258 total thyroid cancers diagnosed over a 2-year period in our institution. This number corresponds to 2.7% of thyroid cancer diagnoses. This number is not only drastically lower than many previously published historic references which typically indicate a 10% to 15% rate of follicular cancers, but also much lower than recently collected data from multi-institutional, large, prospective series. Hundahl et al 1 reported on the National Cancer Database (NCD) registry for thyroid cancers, a cohort consisting of more than 53,000 cases of thyroid cancer diagnosed in the United States between 1985 and In the NCD report, the proportion of papillary cancers was 79% of the total, whereas follicular cancers made up 13%. For a more recent perspective, the National Cancer Institute s Surveillance Epidemiology and End Results (SEER) database, a comprehensive cancer database that captures a crosssection of approximately 26% of the United States population, can be evaluated. From the 2005 SEER report (capturing cases diagnosed between 2001 and 2005), papillary cancers comprised 85% of thyroid cancer diagnoses, whereas follicular carcinomas made up 6.7% 6 (Figure 3 and Figure 4). Because the NCD and SEER make no attempt to collect specific histologic description of tumors entered into the registries, it is obvious that the diagnoses reported in these databases are made by many pathologists from many different regions of the country and likely represent many nuances in diagnostic inquiry. There are several contributing factors that underlie the change in thyroid cancer demographics over the last 30 years. First, analysis of SEER reveals that although the overall incidence of thyroid cancer has significantly increased in 30 years, the increase is nearly all attributable to cancer of the papillary subtype. FIGURE 3. Comparison of thyroid cancer cases from Mount Sinai, SEER, and NCD by percentage of cases diagnosed. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] The overall incidence of follicular thyroid cancer, however, has remained stable since Because of the relative stability in follicular carcinoma incidence, it can be surmised that the increase in papillary thyroid cancer is real and cannot solely be accounted for by redistribution in the histopathologic classification of follicular carcinomas to other diagnostic categories such as follicular variant of papillary carcinoma. If this were the case, the incidence of follicular cancers would have been expected to decrease as these diagnoses were replaced by diagnoses of papillary carcinoma variants. As papillary cancers have become significantly more common, the relative proportion of follicular cancer has seemingly gone down. Analysis of SEER has also shown that since tumor size has been reported in the database (1988), the largest group of new papillary cancers diagnosed is the group of tumors 2 cm or less. 6 Although there have been demonstrable FIGURE 4. Comparison of follicular thyroid carcinomas from Mount Sinai, SEER, and NCD by percentage of cases diagnosed. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] 1632 Diminishing Diagnosis of Follicular Thyroid Carcinoma HEAD & NECK DOI /hed December 2010
5 increases in the incidence rates for the larger tumors, these rates do not come close to comparing to the rates for the smaller tumors. There is an ever-increasing use of high-resolution neck ultrasound scan and FNA biopsy which has likely contributed to improved detection of early thyroid cancers. Over time, this fact may also explain the steady decrease in the group of undifferentiated and anaplastic thyroid carcinomas as well. The change in papillary cancer incidence rates and relative stability of follicular cancer incidence is not likely enough to explain such a reduction in the proportion of follicular cancers currently diagnosed on its own. Changing diagnostic criteria must be considered important in contributing to the current numbers. The most important has been the increased recognition and refinement of criteria by surgical pathologists of the entity of follicular variant of papillary carcinoma, which is based on well-defined cytologic (nuclear) features of papillary carcinoma in a follicular patterned lesion When these well-differentiated tumors are completely encapsulated and show minimal to no invasion, it may be difficult to distinguish them from adenomatous hyperplastic nodules, follicular adenomas, or minimally invasive follicular carcinomas. 12 Particularly problematic to pathologists is defining and applying the so-called minimal diagnostic criteria of the follicular variant of papillary carcinoma, and interobserver variability among expert consultants in thyroid pathology has been documented. 7,8 It has been recognized that papillary carcinoma nuclei may be present in a multifocal pattern and may merge with otherwise benign appearing nuclei within a single lesion, even in a macrofollicular hyperplastic nodule. 12 In addition to the follicular variant of papillary carcinoma, the oncocytic (Hürthle cell) variant of papillary carcinoma has been defined. Indeed, Hürthle cell carcinomas are now classified as the oncocytic variants of 1 of the following: follicular carcinoma, papillary carcinoma, insular carcinoma, or medullary carcinoma. 11 Lastly, adenomatous hyperplastic nodules and follicular adenomas may be overdiagnosed as encapsulated or minimally invasive follicular carcinomas due to the difficulties in diagnosing true capsular and vascular invasion and due to pseudoinvasion of the capsule caused by a previous FNA biopsy. 12 All of these refinements in diagnostic criteria have led to a decreased incidence in the diagnosis of follicular adenomas, encapsulated follicular carcinomas, and Hürthle cell adenomas/carcinomas, not otherwise specified. Recognizing that there exists a group of well-differentiated follicular neoplasms that are difficult to classify histologically as either benign or malignant, the Chernobyl group of pathologists has recently proposed a new term for labeling lesions with either incomplete features of papillary cancer or equivocal invasion. The encapsulated, well-differentiated, follicular neoplasm of undetermined malignant potential has been proposed as a bridging term between lesions that are clearly benign, and those that are clearly malignant. 13 The issue of long-term clinical predictability and utility of this proposed diagnostic category becomes questionable as surgeons would still be forced to make traditional therapeutic decisions (ie, surgery for malignant lesions and observation for benign ones). To date, this diagnosis has not been employed at our institution, but it could be speculated that if it were widely adopted, there would be some decrease in the diagnosis of the follicular variant of papillary carcinoma, and thus, the overall incidence of papillary cancer as a subtype, would be expected to decrease. CONCLUSION In our series of 258 primary thyroid malignancies treated over a 2-year period, we identified only 7 cases (2.7%) of true follicular thyroid carcinoma. When compared to large, cross-sectional and multi-institutional cancer databases such as SEER and NCD, and previously established thyroid cancer proportions, this number is not only drastically lower, but reflects an emerging trend away from the follicular cancer diagnosis; favoring diagnoses such as follicular adenoma and follicular variant of papillary carcinoma. Our proportion of 7 of 258 cases can be favorably compared to series previously reported by LiVolsi and Asa, and DeMay 14,15 in which follicular cancers were identified in just 2% and 1%, respectively. In these reports, similar diagnostic scrutiny was utilized. Lesions with nuclear features suggestive of papillary carcinoma were classified as such, and care was taken to exclude pseudocapsular invasion that may be traumatic in nature. Both improved clinical diagnostics, and evolving diagnostic criteria in thyroid cancer histopathology, has led to a drastic increase in Diminishing Diagnosis of Follicular Thyroid Carcinoma HEAD & NECK DOI /hed December
6 the incidence and proportion of papillary thyroid cancers being diagnosed. This multifactorial change has led to an overall shrinkage in the numbers of true follicular carcinomas seen currently. A change in expected proportions is important for clinicians to take into account when therapeutic options are being considered and when patients are being counseled about their diagnoses. Over time, it seems we are likely to see a continued trend toward decreasing numbers of the nonpapillary subtypes; and, as such, a shift in thyroid cancer management and thyroid cancer outcomes may follow. REFERENCES 1. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., Cancer 1998;83: Albores-Saavedra J, Henson DE, Glazer E, Schwartz AM. Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype-papillary, follicular, and anaplastic: a morphological and epidemiological study. Endocr Pathol 2007;18: Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, JAMA 2006;295: Hodgson NC, Button J, Solorzano CC. Thyroid cancer: is the incidence still increasing? Ann Surg Oncol 2004;11: Hundahl SA, Cady B, Cunningham MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer 2000;89: National Cancer Institute. Surveillance, Epidemiology and End Results Program. Available at cancer.gov. 7. Lloyd RV, Erickson LA, Casey MB, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol 2004;28: Elsheikh TM, Asa SL, Chan JK, et al. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol 2008;130: Albores-Saavedra J, Wu J. The many faces and mimics of papillary thyroid carcinoma. Endocr Pathol 2006;17: Rosai J, Carcangiu ML, DeLellis RA. Tumors of the Thyroid Gland. Atlas of Tumor Pathology, Third Series, Fascicle 5. Armed Forces Institute of Pathology, Washington, D.C DeLellis RA, Lloyd RV, Heitz PU, Eng C. World Health Organization Classification of Tumours. Tumours of Endocrine Organs. IARC, LiVolsi VA, Baloch ZW. Follicular neoplasms of the thyroid: view, biases, and experiences. Adv Anat Pathol 2004;11: Williams ED. Guest Editorial: Two proposals regarding the terminology of thyroid tumors. Int J Surg Pathol 2000;8: LiVolsi VA, Asa SL. The demise of follicular carcinoma of the thyroid gland. Thyroid 1994;4: DeMay RM. Follicular lesions of the thyroid. W(h)ither folicular carcinoma? Am J Clin Pathol 2000;114: Diminishing Diagnosis of Follicular Thyroid Carcinoma HEAD & NECK DOI /hed December 2010
NIFTP: Histopathology of a Cytological Monkey Wrench. B. Wehrli
NIFTP: Histopathology of a Cytological Monkey Wrench B. Wehrli Non-Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma Before 2016 Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like
More informationPredictors of Malignancy in Thyroid Fine-Needle Aspirates Cyst Fluid Only Cases
Predictors of Malignancy in Thyroid Fine-Needle Aspirates Cyst Fluid Only Cases Can Potential Clues of Malignancy Be Identified? Mohammad Jaragh, MD 1 ; V. Bessie Carydis, MMedSci (Cytol) 1 ; Christina
More informationNon-Invasive Follicular Thyroid Neoplasm with Papillary-like Nuclei (NIFTP)
Papillary Thyroid Carcinoma: Follicular Variant Encapsulated Type Replaced by: Non-Invasive Follicular Thyroid Neoplasm with Papillary-like Nuclei (NIFTP) Lester D. R. Thompson www.lester-thompson.com
More informationThyroid Pathology: It starts and ends with the gross. Causes of Thyrophobia. Agenda. Diagnostic ambiguity. Treatment/prognosis disconnect
Thyroid Pathology: It starts and ends with the gross Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology Chair of Pathology and Laboratory Medicine University of Arkansas for
More informationAn Alphabet Soup of Thyroid Neoplasms
Overall Objectives An Alphabet Soup of Thyroid Neoplasms Lester D. R. Thompson www.lester-thompson.com What is the current management of papillary carcinoma? What are the trends and what can we do differently?
More informationResearch Article Papillary Thyroid Cancer, Macrofollicular Variant: The Follow-Up and Analysis of Prognosis of 5 Patients
yroid Research, Article ID 818134, 4 pages http://dx.doi.org/10.1155/2014/818134 Research Article Papillary Thyroid Cancer, Macrofollicular Variant: The Follow-Up and Analysis of Prognosis of 5 Patients
More informationPathology of the Thyroid
Pathology of the Thyroid Thyroid Carcinoma Arising from Follicular Cells 2015-01-19 Prof. Dr. med. Katharina Glatz Pathologie Carcinomas Arising from Follicular Cells Differentiated Carcinoma Papillary
More informationTHE FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA AND NIFTP
THE FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA AND NIFTP FOLLICULAR VARIANT OF PAPILLARY CARCINOMA HISTORICAL PERSPECTIVE FOLLICULAR VARIANT OF PAPILLARY CARCINOMA 1960 described by Dr. Stuart Lindsay
More informationThyroid Cytopathology: Weighing In The Bethesda System
Thyroid Cytopathology: Weighing In The Bethesda System V8 Conflicts No financial consideration Bias Work in the Canadian environment where litigation is less Thyroid cytology is often referred in by small
More informationDIAGNOSIS AND REPORTING OF FOLLICULAR-PATTERNED THYROID LESIONS BY FINE NEEDLE ASPIRATION
Follicular-patterned thyroid lesions, WC Faquin 1 DIAGNOSIS AND REPORTING OF FOLLICULAR-PATTERNED THYROID LESIONS BY FINE NEEDLE ASPIRATION William C. Faquin, M.D., Ph.D Department of Pathology, Massachusetts
More informationVolume 2 Issue ISSN
Volume 2 Issue 3 2012 ISSN 2250-0359 Correlation of fine needle aspiration and final histopathology in thyroid disease: a series of 702 patients managed in an endocrine surgical unit *Chandrasekaran Maharajan
More informationAGGRESSIVE VARIANTS OF PAPILLARY THYROID CARCINOMA DIAGNOSIS AND PROGNOSIS
AGGRESSIVE VARIANTS OF PAPILLARY THYROID CARCINOMA DIAGNOSIS AND PROGNOSIS PAPILLARY THYROID CARCINOMA Clinical Any age Microscopic to large Female: Male= 2-4:1 Radiation history Lymph nodes Prognosis
More informationThe Korean Journal of Cytopathology 15(1) : 60-64, 2004
15 1 The Korean Journal of Cytopathology 15(1) : 60-64, 2004 : INTRODUCTION Papillary carcinoma of the thyroid gland has for long been traditionally diagnosed on the basis of the characteristic papillary
More informationFollicular Derived Thyroid Tumors
Follicular Derived Thyroid Tumors Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology Chair of Pathology and Laboratory Medicine University of Arkansas for Medical Sciences
More informationPitfalls in thyroid tumor pathology. Prof.Valdi Pešutić-Pisac MD, PhD
Pitfalls in thyroid tumor pathology Prof.Valdi Pešutić-Pisac MD, PhD Too many or... Tumour herniation through a torn capsule simulating capsular invasion fibrous capsule with a sharp discontinuity, suggestive
More informationencapsulated thyroid nodule with a follicular architecture and some form of atypia. The problem is when to diagnose
Histological Spectrum of Papillary Carcinoma of Thyroid A Two Years Study Gomathi Srinivasan 1, M. Vennila 2 1 Associate Professor Pathology, Government Medical College, Omandurar Estate, Chennai 600 002
More informationThyroid Nodules: Understanding FNA Cytology (The Bethesda System for Reporting of Thyroid Cytopathology) Shamlal Mangray, MB, BS
Thyroid Nodules: Understanding FNA Cytology (The Bethesda System for Reporting of Thyroid Cytopathology) Shamlal Mangray, MB, BS Attending Pathologist Rhode Island Hospital, Providence, RI DISCLOSURE:
More informationRates of thyroid malignancy by FNA diagnostic category
Williams et al. Journal of Otolaryngology - Head and Neck Surgery 2013, 42:61 ORIGINAL RESEARCH ARTICLE Open Access Rates of thyroid malignancy by diagnostic category Blair A Williams 1*, Martin J Bullock
More informationMost common type of thyroid malignancy-85% of thyroid cancers Most common endocrine malignancy
THE DIAGNOSIS OF PAPILLARY THYROID : How much (or how little) is enough? Virginia A. LiVolsi, MD University of Pennsylvania Most common type of thyroid malignancy-85% of thyroid cancers Most common endocrine
More informationCase year old female presented with asymmetric enlargement of the left lobe of the thyroid
Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.
More informationCase 4 Diagnosis 2/21/2011 TGB
Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.
More informationBackground to the Thyroid Nodule
William C. Faquin, MD, PhD Professor of Pathology Harvard Medical School Director of Head and Neck Pathology Massachusetts Eye and Ear Massachusetts General Hospital THYROID FNA: PART I Background to the
More informationThyroid Cancer: When to Treat? MEGAN R. HAYMART, MD
Thyroid Cancer: When to Treat? MEGAN R. HAYMART, MD ASSOCIATE PROFESSOR OF MEDICINE UNIVERSITY OF MICHIGAN MICHIGAN AACE 2018 ANNUAL MEETING Thyroid Cancer: When Not to Treat? FOCUS WILL BE ON LOW-RISK
More informationThyroid Gland. Protocol applies to all malignant tumors of the thyroid gland, except lymphomas.
Thyroid Gland Protocol applies to all malignant tumors of the thyroid gland, except lymphomas. Procedures Cytology (No Accompanying Checklist) Partial Thyroidectomy Total Thyroidectomy With/Without Lymph
More informationUltrasound-Guided Fine-Needle Aspiration of Thyroid Nodules: New events
Ultrasound-Guided Fine-Needle Aspiration of Thyroid Nodules: New events Sandrine Rorive, M.D., PhD. Erasme Hospital - Université Libre de Bruxelles (ULB) INTRODUCTION The assessment of thyroid nodules
More informationACCME/Disclosures. Questions to Myself? 4/11/2016
The New Diagnostic Paradigms in Thyroid Surgical Pathology and Affects on Reporting of Thyroid Fine-Needle Aspiration Specimens Deliberations, Criticisms & Discussions Zubair W. Baloch, MD, PhD. Professor
More informationTBSRTC 1- Probabilistic approach and Relationship to Clinical Algorithms
The Benefits of a Uniform Reporting System for Thyroid Cytopathology BETHESDA REPORTING SYSTEM Prof. Fernando Schmitt Department of Pathology and Oncology, Medical Faculty of Porto University Head of Molecular
More informationCN 925/15 History. Microscopic Findings
CN 925/15 History 78 year old female. FNA indeterminate lesion right thyroid lobe. Previous THY1C (UK) Bethesda category 1 cyst fluid. Ultrasound showed part solid/cystic changes, indeterminate in nature
More informationFNA of Thyroid. Toward a Uniform Terminology With Management Guidelines. NCI NCI Thyroid FNA State of the Science Conference
FNA of Thyroid NCI NCI Thyroid FNA State of the Science Conference Toward a Uniform Terminology With Management Guidelines Thyroid Thyroid FNA Cytomorphology NCI Thyroid FNA State of the Science Conference
More informationThyroid pathology Practical part
Thyroid pathology Practical part My Algorithm After a good macroscopy and a microscopic overview of the lesion, I especially look at the capsule and the thyroid just above and just beneath the capsule.
More informationParathyroid cancer: Outcome analysis of 16 patients treated at the princess margaret hospital
ORIGINAL ARTICLE Parathyroid cancer: Outcome analysis of 16 patients treated at the princess margaret hospital Boban M. Erovic, MD, 1 David P. Goldstein, MD, MSc, FRCS(C), 1 Dae Kim, MBChB, BDS, MSc, FRCS
More informationEnterprise Interest None
Enterprise Interest None Risk stratification of salivary gland lesions on cytology based on the proposed Milan System for reporting salivary gland cytopathology: A pilot study Kartik Viswanathan, M.D.,
More informationLet s Make Sense of Present & Predict Future. In Light of Past 1/12/2016
The New Diagnostic Paradigms in Thyroid Surgical Pathology and Affects on Reporting of Thyroid Fine Needle Aspiration Specimens Deliberations, Criticisms & Discussions Zubair W. Baloch, MD, PhD. Professor
More informationRepeat Thyroid Nodule Fine-Needle Aspiration in Patients With Initial Benign Cytologic Results
Anatomic Pathology / REPEAT THYROID FINE-NEEDLE ASPIRATION Repeat Thyroid Nodule Fine-Needle Aspiration in Patients With Initial Benign Cytologic Results Melina B. Flanagan, MD, MSPH, 1 N. Paul Ohori,
More informationNIFTP addendum to the RCPath Dataset for thyroid cancer histopathology reports. June 2016
NIFTP addendum to the RCPath Dataset for thyroid cancer histopathology reports June 2016 Authors: Dr Sarah J Johnson, Royal Victoria Infirmary, Newcastle upon Tyne Professor TJ Stephenson, Sheffield Teaching
More informationThyroid Nodules. Family Medicine Refresher Course Geeta Lal MD, FACS April 2, No financial disclosures
Thyroid Nodules Family Medicine Refresher Course Geeta Lal MD, FACS April 2, 2014 No financial disclosures Objectives Review epidemiology Work up of Thyroid nodules Indications for FNAB Evolving role of
More informationDilemmas in Cytopathology and Histopathology
Dilemmas in Cytopathology and Histopathology Yuri E. Nikiforov, MD, PhD Division of Molecular & Genomic Pathology University of Pittsburgh Medical Center, USA Objectives Discuss new WHO classification
More informationThyroid follicular neoplasms in cytology. Ulrika Klopčič Institute of Oncology, Department of Cytopathology, Ljubljana, Slovenia
Thyroid follicular neoplasms in cytology Ulrika Klopčič Institute of Oncology, Department of Cytopathology, Ljubljana, Slovenia Lecture overview importance of FNAB in assessing thyroid lesions follicular
More informationThe Frozen Section: Diagnostic Challenges and Pitfalls
The Frozen Section: Diagnostic Challenges and Pitfalls William C. Faquin, M.D., Ph.D. Director, Head and Neck Pathology Massachusetts General Hospital & Massachusetts Eye and Ear Infirmary Harvard Medical
More informationNew entities in thyroid pathology: update according to the WHO classification
New entities in thyroid pathology: update according to the WHO classification R.R. de Krijger, Dept. of Pathology, University Medical Center and Princess Maxima Center, Utrecht, The Netherlands New issues
More informationUsefulness of Diagnostic Qualifiers for Thyroid Fine-Needle Aspirations With Atypia of Undetermined Significance
Anatomic Pathology / AUS Qualifiers in Thyroid FNAs Usefulness of Diagnostic Qualifiers for Thyroid Fine-Needle Aspirations With Atypia of Undetermined Significance Paul A. VanderLaan, MD, PhD, 1 Ellen
More informationNeuroradiology/Head and Neck Imaging Original Research
Neuroradiology/Head and Neck Imaging Original Research Hobbs et al. FNA of Thyroid Nodules Neuroradiology/Head and Neck Imaging Original Research Hasan A. Hobbs 1 Manisha Bahl 1 Rendon C. Nelson 1,2 James
More informationCAP Cancer Protocol and ecc Summary of Changes for August 2014 Thyroid Agile Release
CAP Cancer Protocol and ecc Summary of Changes for August 2014 Thyroid Agile Release 2 REVISION HISTORY Date Author / Editor Comments 5/19/2014 Jaleh Mirza Created the document 8/12/2014 Samantha Spencer/Jaleh
More informationDistant and Lymph Node Metastases of Thyroid Nodules with No Pathological Evidence of Malignancy: A Limitation of Pathological Examination
Endocrine Journal 2008, 55 (5), 889 894 Distant and Lymph Node Metastases of Thyroid Nodules with No Pathological Evidence of Malignancy: A Limitation of Pathological Examination YASUHIRO ITO, TOMONORI
More informationNormal thyroid tissue
Thyroid Pathology Overview Normal thyroid tissue Normal thyroid tissue with follicles filled with colloid. Thyroid cells form follicles, spheres of epithelial cells (always single layered in health, usually
More information:Well differentiated tumour of uncertain malignant potential. : Encapsulated follicular variant of papillary thyroid carcinoma
WDC-NOS (Well-Differentiated Carcinoma, not otherwise specified): An encapsulated tumor of well-differentiated follicular cells showing obvious capsular and/or blood vessel invasion and having questionable
More informationNIFTP Cytologic Aspects
NIFTP Cytologic Aspects William C. Faquin, MD PhD Director, Head and Neck Pathology Massachusetts General Hospital & Massachusetts Eye and Ear Infirmary Boston, MA USA So, what is the story about FVPTC
More informationThyroid nodules - medical and surgical management. Endocrinology and Endocrine Surgery Manchester Royal Infirmary
Thyroid nodules - medical and surgical management JRE Davis NR Parrott Endocrinology and Endocrine Surgery Manchester Royal Infirmary Thyroid nodules - prevalence Thyroid nodules common, increase with
More informationMedicine. Observational Study. 1. Introduction. 2. Materials and methods. 3. Results OPEN
Observational Study Medicine Ultrasonographic features and clinicopathologic characteristics of macrofollicular variant papillary thyroid carcinoma Yong Sang Lee, MD a,c, Soo Young Kim, MD a,c, Soon Won
More informationRising Trend of Thyroid Cancer An Institutional Study
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 1 Ver. IV (Jan. 2016), PP 77-81 www.iosrjournals.org Rising Trend of Thyroid Cancer An Institutional
More informationSection 2 Original Policy Date 2013 Last Review Status/Date September 1, 2014
Policy Number 2.04.82 Molecular Markers in Fine Needle Aspirates of the Thyroid Medical Policy Section 2 Original Policy Date 2013 Last Review Status/Date September 1, 2014 Disclaimer Our medical policies
More informationThyroid master class. Thyroid Fine needle aspiration cytology and liquid-based techniques: Hologic and Becton Dickinson
Thyroid master class Thyroid Fine needle aspiration cytology and liquid-based techniques: Hologic and Becton Dickinson Principle of LBC Collection of cells in liquid medium Immediate fixation Processor-prepared
More information5/3/2017. Ahn et al N Engl J Med 2014; 371
Alan Failor, M.D. Clinical Professor of Medicine Division of Metabolism, Endocrinology and Nutrition University of Washington April 20, 2017 No disclosures to report 1. Appropriately evaluate s in adult
More informationClinical and Molecular Approach to Using Thyroid Needle Biopsy for Nodular Disease
Clinical and Molecular Approach to Using Thyroid Needle Biopsy for Nodular Disease Robert L. Ferris, MD, PhD Department of Otolaryngology/Head and Neck Surgery and Yuri E. Nikiforov, MD, PhD Division of
More informationOverview of Indeterminate Cytology
83 rd Annual Meeting American Thyroid Association Overview of Indeterminate Cytology Scott Boerner MD FRCPC Head Cytopathology, University Health Network University of Toronto DISCLOSURE Nothing to disclose
More informationMedullary Thyroid Carcinoma. This case was provided by Treant Hospital, Bethesda, Hoogeveen, The Netherlands
Medullary Thyroid Carcinoma This case was provided by Treant Hospital, Bethesda, Hoogeveen, The Netherlands ADS-01504 Rev. 001 2016 Hologic, Inc. All rights reserved. Overview Medullary Thyroid Carcinoma
More informationUpdate on Thyroid FNA The Bethesda System. Shikha Bose M.D. Associate Professor Cedars Sinai Medical Center
Update on Thyroid FNA The Bethesda System Shikha Bose M.D. Associate Professor Cedars Sinai Medical Center Thyroid Nodules Frequent occurrence Palpable: 4-7% of adults Ultrasound: 10-31% Majority benign
More information3/22/2017. Disclosure of Relevant Financial Relationships. Cytomorphologic Thresholds for Classifying Thyroid FNAs as Suspicious and Positive for PTC
Cytomorphologic Thresholds for Classifying Thyroid FNAs as Suspicious and Positive for PTC Tarik M. Elsheikh, MD Professor and Medical Director Anatomic Pathology Cleveland Clinic Laboratories Disclosure
More informationTHYROID CYTOLOGY THYROID CYTOLOGY FINE-NEEDLE-ASPIRATION ANCILLARY TESTS IN THYROID FNA
ANCILLARY TESTS IN THYROID FNA Prof. Fernando Schmitt Department of Pathology and Oncology, Medical Faculty of Porto University Head of Molecular Pathology Unit, IPATIMUP General-Secretary of the International
More information"Atypical": Criteria and
"Atypical": Criteria and Controversies Esther Rossi MD PhD MIAC Division of Anatomic Pathology and Cytology Catholic University of Sacred Heart Rome, Italy CASE HISTORY In 2015, 45 y/o woman underwent
More informationJournal of Diagnostic Pathology 2011 (6); 1: Leading Article
Leading Article Beyond the horizon of current thyroid cytology reporting in Sri Lanka... Lokuhetty MDS Thyroid enlargement is a commonly encountered clinical problem among Sri Lankan patients, be it diffuse
More informationBuilding On The Best A Review and Update on Bethesda Thyroid 2017
Building On The Best A Review and Update on Bethesda Thyroid 2017 Syed Z. Ali, MD, FRCPath, FIAC Professor of Pathology and Radiology The Johns Hopkins Hospital, Baltimore, Maryland USA TBSRTC Diagnostic
More informationChapter 14: Thyroid Cancer
The American Academy of Otolaryngology Head and Neck Surgery Foundation (AAO-HNSF) Presents... Chapter 14: Thyroid Cancer Daiichi Pharmaceutical Corporation, marketers and distributors of FLOXIN Otic (ofloxacin
More informationPathology Reporting of Thyroid Core Needle Biopsy: A Proposal of the Korean. Endocrine Pathology Thyroid Core Needle Biopsy Study Group
Pathology Reporting of Thyroid Core Needle Biopsy: A Proposal of the Korean Endocrine Pathology Thyroid Core Needle Biopsy Study Group Chan Kwon Jung 1 Hye Sook Min 2,3 Hyo Jin Park 2 Dong Eun Song 4 Jang
More information04/09/2018. Follicular Thyroid Tumors Updates in Classification & Practical Tips. Dissecting Indeterminants. In pursuit of the low grade malignancy
Follicular Thyroid Tumors Updates in Classification & Practical Tips Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology Chair of Pathology and Laboratory Medicine University
More informationNCI Thyroid FNA State of the Science Conference. The Bethesda System For Reporting Thyroid Cytopathology
The Bethesda System For Reporting Thyroid Cytopathology Towards a Uniform Terminology With Management Guidelines NCI Thyroid FNA State of the Science Conference Bethesda, MD October 22-23, 2007 154 registrants
More informationNew York, the nation s thyroid gland. Christopher Morley ( ), "Shore Leave"
New York, the nation s thyroid gland Christopher Morley (1890-1957), "Shore Leave" Thyroid Literature Medline Thyroid disease 136,053 Thyroid tumors 33,554 New Paper on Thyroid Disease Every 3 Hours New
More informationCytology for the Endocrinologist. Nicole Massoll M.D
Cytology for the Endocrinologist Nicole Massoll M.D Objectives Discuss slide preperation Definitions of adequacy ROSE (Rapid On-Site Evaluation) Thyroid Cytology Adequacy Nicole Massoll M.D. University
More informationHow good are we at finding nodules? Thyroid Nodules Thyroid Cancer Epidemiology Initial management Long-term follow up Disease-free status
New Perspectives in Thyroid Cancer Jennifer Sipos, MD Assistant Professor of Medicine Division of Endocrinology The Ohio State University Outline Thyroid Nodules Thyroid Cancer Epidemiology Initial management
More informationCytomorphologic Thresholds for Classifying Thyroid FNAs as Suspicious and Positive for PTC
Cytomorphologic Thresholds for Classifying Thyroid FNAs as Suspicious and Positive for PTC Tarik M. Elsheikh, MD Professor and Medical Director Anatomic Pathology Cleveland Clinic Laboratories Case Study
More informationCase #1. Ed Stelow, MD University of Virginia
Case #1 Ed Stelow, MD University of Virginia Imagine, If You Will It s 4:30 on Friday Last cytology case A thyroid FNA from outside that did not have any onsite interpretation It is from a 45-year old
More informationCytological features of well-differentiated tumors of uncertain malignant potential: Indeterminate cytology and WDT-UMP
Endocrine Journal 2012, 59 (6), 483-487 Or i g i n a l Cytological features of well-differentiated tumors of uncertain malignant potential: Indeterminate cytology and WDT-UMP Keiko Nishigami 1), Zhiyan
More informationNoninvasive follicular thyroid neoplasm with papillary-like nuclear features: a single-institutional experience in Japan
2017, 64 (12), 1149-1155 Original Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a single-institutional experience in Japan Mitsuyoshi Hirokawa 1), Miyoko Higuchi 2), Ayana
More informationDifferentiated Thyroid Carcinoma
Differentiated Thyroid Carcinoma The GOOD cancer? Jennifer Sipos, MD Associate Professor of Medicine Director, Benign Thyroid Program Division of Endocrinology, Diabetes and Metabolism The Ohio State University
More informationPotential Pitfalls for False Suspicion of Papillary Thyroid Carcinoma:
SUPPLEMENT 1 SPECIAL ISSUE: CYTOPATHOLOGY OF THE THYROID GLAND Guest Editor: Zubair Baloch Potential Pitfalls for False Suspicion of Papillary Thyroid Carcinoma: A Cytohistologic Review of 22 Cases Xin
More informationsystem and the Bethesda system applied for reporting thyroid cytopathology
Original Research Article A comparative study between conventional system and the Bethesda system applied for reporting thyroid cytopathology M. Mamatha 1*, S. Chandra Sekhar 2, H. Sandhya Rani 3, S. Sandhya
More informationThyroid Nodule. Disclosure. Learning Objectives P A P A P A 3/18/2014. Nothing to disclose.
Thyroid Nodule Evaluating the patient with a thyroid nodule and some management options. Miguel V. Valdez PA C Disclosure Nothing to disclose. Learning Objectives Examination of thyroid gland Options for
More informationHEAD AND NECK ENDOCRINE SURGERY
HEAD AND NECK ENDOCRINE SURGERY OCTOBER 22-23, 2010 THE MARK HOPKINS SAN FRANCISCO, CA THYROID FNA AND CYTOPATHOLOGY THEODORE R. MILLER, MD THE THYROID NODULE Prevalence of palpable nodule: Female ~ 6%
More informationLester D. R. Thompson 1 & David N. Poller 2 & Kennichi Kakudo 3 & Raoul Burchette 4 & Yuri E. Nikiforov 5 & Raja R. Seethala 5
Endocrine Pathology https://doi.org/10.1007/s12022-018-9520-0 An International Interobserver Variability Reporting of the Nuclear Scoring Criteria to Diagnose Noninvasive Follicular Thyroid Neoplasm with
More informationHyalinizing Trabecular Neoplasm of the Thyroid: Controversies in Management
ISPUB.COM The Internet Journal of Endocrinology Volume 2 Number 1 Hyalinizing Trabecular Neoplasm of the Thyroid: Controversies in Management J D'Elia, D Charous, J Miller, J Palazzo, E Pribitkin Citation
More informationASCP Competency Assessment
ASCP Competency Assessment Thyroid Cytopathology Ricardo R. Lastra, MD Michelle R. Pramick, MD Zubair W. Baloch, MD, PhD Department of Pathology & Laboratory Medicine University of Pennsylvania, Perelman
More informationThyroid Nodules. Dr. HAKIMI, SpAK Dr. MELDA DELIANA, SpAK Dr. SISKA MAYASARI LUBIS, SpA
Thyroid Nodules ENDOCRINOLOGY DIVISION ENDOCRINOLOGY DIVISION Dr. HAKIMI, SpAK Dr. MELDA DELIANA, SpAK Dr. SISKA MAYASARI LUBIS, SpA Anatomical Considerations The Thyroid Nodule Congenital anomalies Thyroglossal
More informationIntroduction 10/27/2011. Follicular Lesion/Atypia of Undetermined Significance
Follicular Lesion/Atypia of Undetermined Significance Tarik M. Elsheikh, MD Cleveland Clinic Cleveland, Ohio Diagnostic Categories Proposed by Bethesda System/NCI Thyroid Conference 1. Benign 2. Follicular
More informationPrognostic value of the 8 th tumor-node-metastasis classification for follicular carcinoma and poorly differentiated carcinoma of the thyroid in Japan
2018, 65 (6), 621-627 ORIGINAL Prognostic value of the 8 th tumor-node-metastasis classification for follicular carcinoma and poorly differentiated carcinoma of the thyroid in Japan Yasuhiro Ito 1), Akira
More information2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines
2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines Angela M. Leung, MD, MSc, ECNU November 5, 2016 Outline Workup of nontoxic thyroid nodule(s) Ultrasound FNAB Management of FNAB results
More informationDisclosures. Parathyroid Pathology. Objectives. The normal parathyroid 11/10/2012
Disclosures Parathyroid Pathology I have nothing to disclose Annemieke van Zante MD/PhD Assistant Professor of Clinical Pathology Associate Chief of Cytopathology Objectives 1. Review the pathologic features
More informationThe diagnostic value of fine-needle aspiration cytology in the assessment of thyroid nodules: a retrospective 5-year analysis
The diagnostic value of fine-needle aspiration cytology in the assessment of thyroid nodules: a retrospective 5-year analysis GPS Yeoh, KW Chan Objective. To audit the diagnostic accuracy and value of
More informationClinical Significance of Distinguishing Between Follicular Lesion and Follicular Neoplasm in Thyroid Fine-Needle Aspiration Biopsy
Ann Surg Oncol (2009) 16:3146 3153 DOI 10.1245/s10434-009-0666-3 ORIGINAL ARTICLE ENDOCRINE TUMORS Clinical Significance of Distinguishing Between Follicular Lesion and Follicular Neoplasm in Thyroid Fine-Needle
More informationNEOPLASMS OF THE THYROID PATHOLOGY OF PARATHYROID GLANDS. BY: Shifaa Qa qa
NEOPLASMS OF THE THYROID PATHOLOGY OF PARATHYROID GLANDS BY: Shifaa Qa qa Neoplasmas of the thyroid thyroid nodules Neoplastic ---- benign, malignant Non neoplastic Solitary nodules ----- neoplastic Nodules
More informationCase #1 FNA of nodule in left lobe of thyroid in 67 y.o. woman
Challenging Cases Manon Auger M.D., F.R.C.P. (C) Professor, Department of Pathology McGill University Director, Cytopathology Laboratory McGill University it Health Center Case #1 FNA of nodule in left
More informationUpdate to the College of American Pathologists Reporting on Thyroid Carcinomas
Head and Neck Pathol (2009) 3:86 93 DOI 10.1007/s12105-009-0109-2 PROCEEDINGS OF THE 2009 NORTH AMERICAN SOCIETY OF HEAD AND NECK PATHOLOGY COMPANION MEETING (BOSTON, MA) Update to the College of American
More informationRE-AUDIT OF THYROID FNA USING THE THY GRADING SYSTEM AND HISTOLOGY AT SUNDERLAND ROYAL HOSPITAL, 2011
Audit: RE-AUDIT OF THYROID FNA USING THE THY GRADING SYSTEM AND HISTOLOGY AT SUNDERLAND ROYAL HOSPITAL, 2011 Auditors: Dr Lena Wilkinson SpR Histopathology Dr. Debra Milne Consultant Histocytopathologist
More informationA variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study
ORIGINAL ARTICLE A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study Joon-Hyop Lee, MD, Yoo Seung Chung, MD, PhD,* Young Don Lee, MD, PhD
More informationScholars Journal of Medical Case Reports
Scholars Journal of Medical Case Reports Sch J Med Case Rep 2017; 5(9):521-526 Scholars Academic and Scientific Publishers (SAS Publishers) (An International Publisher for Academic and Scientific Resources)
More informationSetting The setting was secondary care. The economic study was conducted in the USA.
Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid Udelsman R, Westra W H, Donovan P I, Sohn T A, Cameron J L Record Status This is a critical abstract
More informationGoiter, Nodules and Tumors
Goiter, Nodules and Tumors Howard J. Sachs, MD www.12daysinmarch.com Thyroid Cancer Anaplastic Medullary Thyroid Cancer Anaplastic Medullary Thyroid Cancer Anaplastic Medullary Anaplastic Medullary MEN
More informationWork Up & Evaluation of Thyroid Nodules In 2013: State of The Art
Work Up & Evaluation of Thyroid Nodules In 2013: State of The Art BC Surgical Oncology Network, Fall Update Todd McMullen MD PhD FRCSC FACS Endocrine Surgeon Divisions of General Surgery and Oncology Director,
More informationBE AWARE OF THE PATIENT WITH BENIGN FOLLICULAR THYROID LESION HISTOLOGY AND RISING THYROGLOBULIN LEVEL
ENDOCRINE PRACTICE Rapid Electronic Article in Press Rapid Electronic Articles in Press are preprinted manuscripts that have been reviewed and accepted for publication, but have yet to be edited, typeset
More informationORIGINAL ARTICLE. Influence of Previous Radiation Exposure on Pathologic Features and Clinical Outcome in Patients With Thyroid Cancer
ORIGINAL ARTICLE Influence of Previous Radiation Exposure on Pathologic Features and Clinical Outcome in Patients With Thyroid Cancer Raewyn M. Seaberg, MD, PhD; Spiro Eski, MD; Jeremy L. Freeman, MD,
More informationB. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life.
B. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life. b. Deficiency of dietary iodine: - Is linked with a
More information